Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

84.32 -2.69 (-3.09%)

Official Closing Price Updated: 4:10 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

55 56 Next >

Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours ↗

July 17, 2025

Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said.

Via Stocktwits

Topics Artificial Intelligence

Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss ↗

July 17, 2025

The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.

Via Investor's Business Daily

Topics Government Stocks

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 17, 2025

Via Benzinga

Wondering what's happening in today's S&P500 pre-market session? ↗

July 17, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

A Preview Of Abbott Laboratories's Earnings ↗

July 16, 2025

Via Benzinga

Dow Futures Edge Lower As Trump, Powell Feud Escalates, Earnings Take Centerstage: TSMC, PEP, UAL, GE Among Stocks To Watch ↗

July 17, 2025

While Dow Jones futures were down 0.12% at the time of writing, the S&P 500 futures were up 0.06%.

Via Stocktwits

Topics ETFs Economy Government

Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates

July 17, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of...

Via StockStory

Earnings Scheduled For July 17, 2025 ↗

July 17, 2025

Via Benzinga

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

July 16, 2025

Via Benzinga

Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 16, 2025

Via Benzinga

Abbott Laboratories (ABT) Q2 Earnings: What To Expect

July 15, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Meta To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

July 15, 2025

Via Benzinga

Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity

July 15, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

3 Profitable Stocks to Research Further

July 14, 2025

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

Via StockStory

Topics Economy Supply Chain

3 Dividend Growth Stocks to Buy and Hold ↗

July 12, 2025

Via The Motley Fool

Topics Intellectual Property

Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

July 08, 2025

Via Benzinga

Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

July 08, 2025

Via Benzinga

2 Dividend Stocks to Buy for Decades of Passive Income ↗

July 06, 2025

Via The Motley Fool

Topics Intellectual Property

1 S&P 500 Stock to Research Further and 2 to Keep Off Your Radar

July 03, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids ↗

July 01, 2025

A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.

Via Investor's Business Daily

Got $500? 2 Healthcare Stocks to Buy and Hold Forever ↗

June 28, 2025

Via The Motley Fool

Topics Artificial Intelligence

How Is The Market Feeling About Abbott Laboratories? ↗

June 27, 2025

Via Benzinga

Uncover the latest developments among S&P500 stocks in today's session. ↗

June 26, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy ↗

June 27, 2025

The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in.

Via Benzinga

Thursday's session: top gainers and losers in the S&P500 index ↗

June 26, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

June 26, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever ↗

June 26, 2025

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

Via The Motley Fool

Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables ↗

June 25, 2025

Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom.

Via Stocktwits

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?

June 17, 2025

Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors...

Via StockStory

Topics Stocks Supply Chain

ABBOTT LABORATORIES (NYSE:ABT) – A Quality Stock Worth Considering ↗

June 12, 2025

ABBOTT LABORATORIES (NYSE:ABT) meets key quality investing criteria with strong revenue growth, high ROIC, and solid financial health, making it a stock worth considering for long-term portfolios.

Via Chartmill

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

55 56 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.